ArticleBMC cancer2016

Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients.

Archana Anantharaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.